Literature DB >> 8259800

Estimates of the US health impact of influenza.

K M Sullivan1, A S Monto, I M Longini.   

Abstract

OBJECTIVES: Data from the Tecumseh Community Health Study were used to estimate excess morbidity owing to influenza, and results were compared with estimates made previously using different methodology for an Institute of Medicine report.
METHODS: Study participants from Tecumseh, Michigan, were classified as infected or noninfected based on laboratory results. The excess numbers of respiratory illnesses, respiratory illness days, and bed and restricted activity days experienced by the infected compared with the noninfected were estimated.
RESULTS: The number of excess influenza-related respiratory illnesses was lower than that estimated in the Institute of Medicine report, in which all illnesses of certain characteristics occurring during an influenza season were attributed to influenza. It is now estimated that the US population under 20 years of age experiences a yearly average of 13.8 to 16.0 million influenza-related excess respiratory illnesses; for older individuals, the yearly estimate is 4.1 to 4.4 million excess illnesses.
CONCLUSIONS: For public health purposes, estimates of excess morbidity as well as of total morbidity associated with influenza should be used in setting health priorities.

Entities:  

Mesh:

Year:  1993        PMID: 8259800      PMCID: PMC1694912          DOI: 10.2105/ajph.83.12.1712

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  12 in total

1.  A serological recapitulation of human infection with different strains of influenza virus.

Authors:  T FRANCIS; F M DAVENPORT; A V HENNESSY
Journal:  Trans Assoc Am Physicians       Date:  1953

2.  Simulation of mechanisms of viral interference in influenza.

Authors:  E Ackerman; I M Longini; S K Seaholm; A S Hedin
Journal:  Int J Epidemiol       Date:  1990-06       Impact factor: 7.196

3.  The Tecumseh study of respiratory illness. 3. Incidence and periodicity of respiratory syncytial virus and Mycoplasma pneumoniae infections.

Authors:  A S Monto; S K Lim
Journal:  Am J Epidemiol       Date:  1971-09       Impact factor: 4.897

4.  The Tecumseh study of respiratory illness. II. Patterns of occurrence of infection with respiratory pathogens, 1965-1969.

Authors:  A S Monto; J J Cavallaro
Journal:  Am J Epidemiol       Date:  1971-09       Impact factor: 4.897

Review 5.  Serious morbidity and mortality associated with influenza epidemics.

Authors:  W P Glezen
Journal:  Epidemiol Rev       Date:  1982       Impact factor: 6.222

6.  Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981.

Authors:  A S Monto; J S Koopman; I M Longini
Journal:  Am J Epidemiol       Date:  1985-06       Impact factor: 4.897

7.  The Tecumseh Study of Respiratory Illness. IX. Occurence of influenza in the community, 1966--1971.

Authors:  A S Monto; F Kioumehr
Journal:  Am J Epidemiol       Date:  1975-12       Impact factor: 4.897

8.  The Tecumseh study of respiratory illness. I. Plan of study and observations on syndromes of acute respiratory disease.

Authors:  A S Monto; J A Napier; H L Metzner
Journal:  Am J Epidemiol       Date:  1971-09       Impact factor: 4.897

9.  Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985.

Authors:  K J Lui; A P Kendal
Journal:  Am J Public Health       Date:  1987-06       Impact factor: 9.308

10.  Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses.

Authors:  T Sonoguchi; H Naito; M Hara; Y Takeuchi; H Fukumi
Journal:  J Infect Dis       Date:  1985-01       Impact factor: 5.226

View more
  48 in total

1.  Economic impact of providing workplace influenza vaccination. A model and case study application at a Brazilian pharma-chemical company.

Authors:  E Burckel; T Ashraf; J P de Sousa Filho; E Forleo Neto; H Guarino; C Yauti; B Barreto F de; L Champion
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

Review 2.  Individual and community impact of influenza.

Authors:  A S Monto
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

3.  Economic evaluations of influenza vaccination in healthy working-age adults. Employer and society perspective.

Authors:  S C Wood; V H Nguyen; C Schmidt
Journal:  Pharmacoeconomics       Date:  2000-08       Impact factor: 4.981

Review 4.  Pharmacoeconomics of influenza vaccination in the elderly: reviewing the available evidence.

Authors:  M J Postma; R M Baltussen; M L Heijnen; L T de Berg; J C Jager
Journal:  Drugs Aging       Date:  2000-09       Impact factor: 3.923

Review 5.  Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.

Authors:  Maarten J Postma; Paul Jansema; Marianne L L van Genugten; Marie-Louise A Heijnen; Johannes C Jager; Lolkje T W de Jong-van den Berg
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  Health impact of influenza in the United States.

Authors:  K M Sullivan
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

7.  Same influenza vaccination strategies but different outcomes across US cities?

Authors:  Claudia Taylor; Achla Marathe; Richard Beckman
Journal:  Int J Infect Dis       Date:  2010-09       Impact factor: 3.623

Review 8.  Antiviral agents for influenza: a comparison of cost-effectiveness data.

Authors:  Larry D Lynd; Ron Goeree; Bernie J O'Brien
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

9.  Racial and ethnic disparities in influenza vaccination among elderly adults.

Authors:  María C Rangel; Victor J Shoenbach; Kristen A Weigle; Vijaya K Hogan; Ronald P Strauss; Shrikant I Bangdiwala
Journal:  J Gen Intern Med       Date:  2005-05       Impact factor: 5.128

Review 10.  Influenza.

Authors:  Tom Jefferson
Journal:  BMJ Clin Evid       Date:  2009-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.